Clinical Trials Logo

Filter by:
NCT ID: NCT05762692 Recruiting - Deep Sedation Clinical Trials

High-flow Nasal Oxygenation During Deep Sedation in Pediatric Dental Patients

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

It is important to choose an appropriate oxygenation technique during intravenous deep sedation in pediatric dental treatment. The study is to evaluate the efficacy and safety of high-flow nasal oxygenation in intravenous deep sedation in pediatric dental patients.

NCT ID: NCT05762575 Completed - Clinical trials for Single-port Laparoscopic Surgery

Application of Spaghetti Knotting Technology in Single-hole Laparoscopic Suturing Instructional Program on the Basis of Multidirectional Stitching Technology.

Start date: August 25, 2022
Phase:
Study type: Observational

The surgeon's knot-tying technique plays a crucial role in the recovery of patients after single-port laparoscopy. Knot tying is very challenging in minimally invasive surgery and is a critical skill in advanced surgery. In this study, investigators introduce a new knotting technique, compare it with the traditional knotting technique in many aspects, and also discuss its application in the teaching of single-port laparoscopic knotting.

NCT ID: NCT05762510 Recruiting - Clinical trials for Transfusion Dependent Beta-Thalassemia

A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]

Start date: February 22, 2023
Phase: Early Phase 1
Study type: Interventional

This is a single-arm, open label, single-dose study in subjects with transfusion dependent β-thalassaemia. The study will evaluate the safety and efficacy of autologous CD34+ Human Hematopoietic Stem Cells that was transduced with LentiRed Lentivrial vector.

NCT ID: NCT05762094 Recruiting - Clinical trials for Bacterial Infections

A Retrospective Study on Personalized Dosing Strategy of Patients Treated by Carbapenems: 2018-2021

Start date: March 2023
Phase:
Study type: Observational

Patients may benefit from the personalized carbapenem dosing strategy based on pharmacokinetics. The objective of this study is to retrospectively review and analyze the clinical outcomes of patients with different dosing strategy.

NCT ID: NCT05762029 Recruiting - Clinical trials for Extracorporeal Membrane Oxygenation

Treatment of Extracorporeal Membrane Oxygenation in Severe Poisoning

Start date: November 26, 2022
Phase:
Study type: Observational

This is a prospective, multicentre clinical study to determine the value of the Extracorporeal Membrane Oxygenation in the treatment of critically ill poisoning patients and whether there are significant differences in the prognosis of different types or doses of poison/drug poisoning. These conclusions may guide us on how to correctly perform Extracorporeal Membrane Oxygenation, including whether or when should this treatment enabled, the mode of Extracorporeal Membrane Oxygenation, whether to combine blood purification, treatment schedule and disembarkation time.

NCT ID: NCT05761938 Recruiting - Glomerulonephritis Clinical Trials

A Study of Rituximab in Frontline Therapy for Glomerulonephritis

Start date: February 1, 2023
Phase:
Study type: Observational

This study included patients with glomerulonephritis who planned to receive rituximab treatment, and observed the efficacy and safety of rituximab in different glomerulonephritis in the real world. According to the pathological types of glomerulonephritis, they were divided into two cohorts : membranous nephropathy ( MN ) group or minimal change disease / focal segmental glomerulosclerosis ( MCD / FSGS ) group.

NCT ID: NCT05761821 Recruiting - Clinical trials for Complication of Surgical Procedure

Key Factors of Leadless Pacemaker Implantation With Implantation Site, Complications and Prognosis

Start date: October 1, 2022
Phase:
Study type: Observational

To investigate the relationship between key variables in leadless pacemaker implantation with implantation site, intraoperative complications and prognosis.

NCT ID: NCT05761704 Recruiting - Clinical trials for Non-valvular Atrial Fibrillation

Exploratory Observation of Two Short-term Regimens After LAA Occlusion by LAMax LAAC® Device for Subjects With Non-valvular Atrial Fibrillation

Start date: November 16, 2023
Phase: N/A
Study type: Interventional

This is a prospective, single-center, randomized, exploratory clinical observation to explore the overall benefit of short-term dual antiplatelet or novel oral anticoagulant regimens after left atrial appendage (LAA) occlusion by LAMax LAAC® occluder for subjects with non-valvular atrial fibrillation (AF), which will provide a basis for subsequent research on real-world safety and efficacy of LAA closure (LAAC).

NCT ID: NCT05761652 Recruiting - COVID-19 Clinical Trials

An Early Warning Model for Assessing the Onset, Progression and Sequelae of COVID-19

Start date: December 1, 2022
Phase:
Study type: Observational

Based on the characteristics of symptoms, differences in physical and chemical examinations and tests, and characteristics of traditional Chinese medicine (TCM) disease differentiation and syndrome differentiation, the evaluation indicators for the clinical early warning model were screened, and the "three-level early warning mechanism for COVID-19 patients at high risks, with progression to severe cases and sequelae was constructed.

NCT ID: NCT05761548 Recruiting - Premature Birth Clinical Trials

Study on the Development of Neonatal Cerebral Blood Flow Based on Ultrafast Ultrasound Doppler Imaging

Start date: May 19, 2022
Phase:
Study type: Observational

Recently, with the development of perinatal medicine in China, the establishment of neonatal intensive care unit (NICU) and the improvement of respiratory support technology, the survival rate of preterm and term neonates has been significantly improved. However, the brain development of preterm neonates is incomplete compared with that of full-term neonates. Therefore, during the extrauterine cultivation of preterm neonates, clinical intervention should be carried out according to their brain development to achieve the same development status as that of full-term neonates. There are many clinical inspection methods to monitor the brain development of preterm neonates, such as EEG, functional near-infrared spectroscopy imaging, etc. However, these technologies cannot assess the brain development of premature infants systematically and completely. Because of the existence of neurovascular coupling, brain function and cerebral blood flow are closely related, so the detection of cerebral blood flow can reflect brain development and brain function. Ultrafast ultrasound power Doppler imaging technology is an emerging, real-time, high-resolution microvascular imaging technology. In this study, we first used ultrafast ultrasound power Doppler imaging technology to image the cerebral blood flow of preterm neonates at different gestational ages to evaluate the development of cerebral blood flow of preterm and term neonates and provide guidance for the clinical intervention of preterm neonates.